Portfolio Lab

Argan Inc

  • Stock
  • Ticker AGX
  • ISIN US04010E1091
  • NYSE

Industrials · Construction and building materials · USA

$268.94 −9.10%
Close of 20 Nov 2026
Open in backtest

Performance, volatility and drawdowns of Argan Inc since 11/2016, with distributions reinvested and calculated in US dollars. As of 20 Nov 2026.

Performance

AGXGlobal equities (VT)

$10,000 grew to $54,943. Global equities (VT): $29,042.

Distributions reinvested, before taxes and brokerage costs. Dashed: Global equities (VT) for comparison.

Declines from the peak

Lowest point −67.2% in 11/2026, measured from the peak in 06/2026. The old peak has not been reached again yet.

1-year return
−23.5%
5-year return p.a.
+47.4%
10-year return p.a.
+18.6%
Volatility p.a.
40.0%
Largest decline
−67.2%

Financial statements

Amounts in $ millions from filings with the SEC, earnings per share in $; fourth quarter and quarterly cash flow derived from year-to-date figures

Quarter end10/202401/202504/202507/202510/202501/202604/202607/2026
Income statement
Revenue257232194238251262291384
Gross profit4448374447666174
Operating income3033243033484557
EBITDA3133253133484657
Net income2831233531494653
Earnings per share2.002.241.602.502.173.473.243.76
Balance sheet
Total assets7698367928831,0511,1861,2861,401
Liabilities440484428490631724813894
Equity329352364393420462474507
Cash175145189178306339356364
Cash flow
Operating cash flow3245353517217211397
Capital expenditure-2.5-1.4-0.4-1.7-0.6-1.2-2.4-5.3
Free cash flow2943353317217111192

Value it:DCF calculatorMultiples calculator

Annual returns

Best year 2024 at +198.3%, weakest 2017 at −34.3%. 5 of 9 full years were positive. * partial year.

Quarterly reports

Filing date with the SEC and earnings per share of the quarter

DayEarnings per share
2 Sep 2026$3.76
4 Jun 2026$3.24
26 Mar 2026$3.47
4 Dec 2025$2.17
4 Sep 2025$2.50
4 Jun 2025$1.60
27 Mar 2025$2.24
5 Dec 2024$2.00
5 Sep 2024$1.31
6 Jun 2024$0.58
11 Apr 2024$0.89
6 Dec 2023$0.40

Key metrics

Metrics of 15 Nov 2026; P/E, P/B, P/S, market cap and dividend yield at the last close.

Valuation

Market cap
€3.4bn
Market cap in trading currency
$3.77bn
Enterprise value
$3.23bn
P/E
21.3
P/S
3.18
P/B
7.44
EV/Sales
2.71
EV/EBITDA
17.5
Earnings yield
4.7%
FCF yield
14.5%

Results (last four quarters)

Revenue
$1.19bn
Gross profit
$248m
EBITDA
$185m
Net income
$179m
Earnings per share
$12.64
Revenue per share
$84.69
Revenue growth
+61.5%
Earnings growth
+51.1%

Profitability

Gross margin
20.9%
Operating margin
15.4%
Net margin
15.1%
Return on equity
39.8%
Return on assets
12.8%

Balance sheet and cash flow

Cash
$548m
Cash per share
$39.05
Financial debt
–
Debt/equity %
–
Current ratio
1.50
Book value per share
$36.13
Operating cash flow
$555m
Free cash flow
$546m

Dividend

Dividend yield
0.82%
Dividend (12 months)
$2.20
Yield (12 months)
0.82%
Payout ratio
17%
Ex-dividend date
22 Oct 2026

Shares and trading

Shares outstanding
14.0m
Volume
376,258
Avg. volume 3 months
359,351
Relative volume
1.1

Price and technicals

Price
$268.94
1 day
−9.1%
52-week high
$798.55
52-week low
$261.21
Distance to 52-week high
−66.3%
Distance to 52-week low
+3.0%
Distance to 50-day line
−23.1%
Distance to 200-day line
−47.9%
RSI (14)
35
Volatility 1M
99.8%

Performance

1 week
−12.2%
1 month
−18.6%
3 months
−42.7%
6 months
−59.0%
YTD
−14.2%
1 year
−25.0%

Dates

Fiscal year end
31 Jan 2026
Most recent quarter
31 Jul 2026

Frequently asked questions

How has AGX performed since 11/2016?

$10,000 grew to $54,943 by 20 Nov 2026, which is +18.6% per year. Distributions are reinvested; taxes and brokerage costs are not deducted.

How volatile is AGX?

Volatility was 40.0% per year, measured on monthly returns. The largest decline from a peak was −67.2%, with the low in 11/2026.

How does AGX compare with a broad equity ETF?

Over the same period Global equities (VT) returned +11.3% per year at 15.1% volatility, AGX returned +18.6% at 40.0%. The correlation of monthly returns was 0.27; 1 would mean they moved in lockstep.

Which currency are the figures in?

In US dollars, the currency of the US listing.

Not investment advice. Metrics and financial statements calculated from the company's mandatory filings with the SEC, without guarantee; amounts in US dollars.

Reference data of securities: source ESMA (FIRDS reference data) and SEC (EDGAR).

Not investment advice: results in Portfolio Lab are model calculations based on historical data and your inputs. Past performance is not a reliable indicator of future results.

Argan Inc (AGX): Return and risk | Portfolio Lab